Compare Vanguard Ultra Short Bond ETF (VUSB) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Ultra Short Bond ETF vs GeneDx Holdings Corp — how do they compare? Vanguard Ultra Short Bond ETF trades at $49.69, while GeneDx Holdings Corp trades at $82.51 (market cap $2.44B). The key difference: GeneDx Holdings Corp is trading nearer its 52-week high, Vanguard Ultra Short Bond ETF nearer its low. Which is the better fit depends on your goals.
| VUSB | WGS | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $50.03 | $167.51 |
52-Week Low | $49.60 | $34.51 |
Market Cap | — | $2.44B |
Enterprise Value | — | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VUSB trades at $49.685, showing minimal daily movement with a 0.05% gain. Technical indicators signal a bearish trend, with moving averages and key momentum oscillators like the ADX indicating selling pressure. Recent news highlights the ETF's focus on short-term bonds amid expectations of Federal Reserve rate hikes, positioning it as a potential hedge against interest rate risk.
The outlook for VUSB is cautious due to bearish technical signals and sensitivity to interest rate changes. Opportunities lie in its short-term bond strategy if rates rise, but risks include market volatility and economic shifts. Investors should weigh the ETF's defensive role against prevailing macroeconomic uncertainties.
GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.
Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Vanguard Ultra Short Bond ETF
VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.
Read more on VUSB →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
